Literature DB >> 32123970

Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor.

Meltem Ocak1, Türkay Toklu2, Emre Demirci2, Nalan Selçuk2, Levent Kabasakal3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32123970     DOI： 10.1007/s00259-020-04725-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  1 in total

Review 1.  Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy.

Authors:  Shaunak Navalkissoor; Ashley Grossman
Journal:  Neuroendocrinology       Date:  2018-10-23       Impact factor: 4.914
  1 in total
  5 in total

1.  Almost Complete Response with a Single Administration 225Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary.

Authors:  Nalan Alan Selçuk; Emre Demirci; Meltem Ocak; Türkay Toklu; Selçuk Ergen; Levent Kabasakal
Journal:  Mol Imaging Radionucl Ther       Date:  2022-06-27

Review 2.  Targeted alpha-particle therapy in neuroendocrine neoplasms: A systematic review.

Authors:  Thuan Tzen Koh; Eva Bezak; David Chan; Gabrielle Cehic
Journal:  World J Nucl Med       Date:  2021-08-20

3.  Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes.

Authors:  Nadia Benabdallah; William Scheve; Nicholas Dunn; Delynn Silvestros; Paul Schelker; Diane Abou; Uday Jammalamadaka; Richard Laforest; Zekun Li; Jonathan Liu; David H Ballard; Nichole M Maughan; Hiram Gay; Brian C Baumann; Robert F Hobbs; Buck Rogers; Amir Iravani; Abhinav K Jha; Farrokh Dehdashti; Daniel L J Thorek
Journal:  Theranostics       Date:  2021-09-27       Impact factor: 11.556

4.  Quantitative SPECT/CT imaging of lead-212: a phantom study.

Authors:  Monika Kvassheim; Mona-Elisabeth R Revheim; Caroline Stokke
Journal:  EJNMMI Phys       Date:  2022-08-04

5.  Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.

Authors:  Yong Du; Angel Cortez; Anders Josefsson; Mohammadreza Zarisfi; Rebecca Krimins; Eleni Liapi; Jessie R Nedrow
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.